- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03278756
Online Cognitive Control Training for Remitted Depressed Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Prospective studies have linked impaired cognitive control to increased cognitive vulnerability for future depression. Importantly, experimental studies indicate that cognitive control training can be used to reduce rumination and depressive symptomatology in MDD (major depressive disorder) and RMD (remitted depressed) samples. Provided that remitted depressed patients form a high-risk group for developing future depressive episodes, the current study will explore whether an internet-delivered cognitive control training can be used to reduce vulnerability for future depression in remitted depressed patients.
A computer training, consisting of 10 sessions of 15 minutes each, will be administered to participants, which are remitted depressed patients. This training can either be a cognitive control training, using an adaptive paced auditory serial addition task, or an active control training, with a low cognitive load task.
Dependent variables will be assessed pre- and post-training, as well as 3 and 6 months after the training, and consist of depressive symptomatology, related variables and cognitive control measures.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Oost-Vlaanderen
-
Gent, Oost-Vlaanderen, Belgium, 9000
- Ghent University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- History of ≥ 1 depressive episodes (major or bipolar)
- Currently in stable full or partial remission (≥ 3 months)
Exclusion Criteria:
- Major depressive disorder (current or less than 3 months in remission)
- Bipolar disorder (current or less than 3 months in remission)
- Psychotic disorder (current and/or previous)
- Neurological impairments (current and/or previous)
- Excessive substance abuse (current and/or previous)
- No ongoing psychotherapeutic treatment (maintenance treatment is allowed, but with a frequency of less than once every three weeks)
- Use of antidepressant medication is allowed if kept at a constant level
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cognitive Control Training
A cognitive control training, consisting of 10 sessions of 15 minutes each, will be administered.
The task in this training is an adaptive paced auditory serial addition task, where participants need to click on the sum of the last two heard digits.
|
10 sessions of an adaptive paced auditory serial addition task, each lasting 15 minutes, over the course of two weeks.
|
|
Active Comparator: Active Control Training
An active control training, consisting of 10 sessions of 15 minutes each, will be administered.
The task in this training is an adaptive low load cognitive task, where participants need to click on the last heard digit.
|
10 sessions of an low cognitive load task, each lasting 15 minutes, over the course of two weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in depressive symptomatology
Time Frame: Assessed at pre-training assessment and at 6 months follow-up
|
Measured by the Beck Depression Inventory - II (BDI-II)
|
Assessed at pre-training assessment and at 6 months follow-up
|
|
Change in depressive symptomatology
Time Frame: Assessed at pre-training assessment, at post-training assessment (within 1 week of completing the training), at 3 months follow-up and at 6 months follow-up
|
Measured by the Depression Anxiety Stress Scales (DASS)
|
Assessed at pre-training assessment, at post-training assessment (within 1 week of completing the training), at 3 months follow-up and at 6 months follow-up
|
|
Change in depressive rumination (brooding)
Time Frame: Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
|
Measured by the Ruminative Response Scale (RRS), especially the brooding subscale
|
Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in cognitive emotion regulation strategies
Time Frame: Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
|
Measured by the Cognitive Emotion Regulation Questionnaire (CERQ)
|
Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
|
|
Change in quality of life
Time Frame: Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
|
Measured by the Quality of Life in Depression Scale (QLDS)
|
Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
|
|
Remission from depression
Time Frame: Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
|
Measured by the Remission of Depression Questionnaire (RDQ)
|
Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
|
|
Resilience
Time Frame: Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
|
Measured by the Connor-Davidson Resilience Scale (CD-RISC)
|
Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
User engagement
Time Frame: Assessed at post-training assessment (within 1 week of completing the training) and at 3 months follow-up
|
Measured by the User Engagement Scale (UES)
|
Assessed at post-training assessment (within 1 week of completing the training) and at 3 months follow-up
|
|
Threatening experiences
Time Frame: Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
|
Measured by the List of Threatening Experiences (LTE)
|
Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
|
|
Effortful control
Time Frame: Assessed at pre-training assessment and at 6 months follow-up
|
Measured by the subscale Effortful Control (EC) from the Adult Temperament Questionnaire (ATQ)
|
Assessed at pre-training assessment and at 6 months follow-up
|
|
Credibility and Expectancy
Time Frame: Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
|
Measured by the Credibility/Expectancy Questionnaire
|
Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
|
|
Behavioral measure for cognitive control
Time Frame: Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
|
Measured by the non-adaptive Paced Auditory Serial Addition Task (PASAT)
|
Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ernst HW Koster, PhD, University Ghent
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B/14730/RMD
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Major Depression in Remission
-
University GhentWithdrawn
-
University GhentCompleted
-
University of British ColumbiaMichael Smith Foundation for Health ResearchTerminated
-
University of ManchesterCompletedMajor Depression (in Remission)United Kingdom
-
The Hong Kong Polytechnic UniversityActive, not recruitingHealthy | Major Depression in RemissionChina
-
Mclean HospitalActive, not recruitingMajor Depression in RemissionUnited States
-
University GhentUniversity Hospital, Ghent; Research Foundation FlandersRecruitingMajor Depression in RemissionBelgium
-
University GhentUniversity Hospital, Ghent; Research Foundation FlandersCompletedMajor Depression in RemissionBelgium
-
University of British ColumbiaCentre for Addiction and Mental Health; Canadian Institutes of Health Research... and other collaboratorsRecruitingMajor Depressive Disorder, Recurrent, in RemissionCanada
-
State University of New York at BuffaloCompletedDepressive Symptoms | Major Depressive Disorder, Recurrent, in RemissionUnited States
Clinical Trials on Cognitive control training
-
Universidad Nacional de Educación a DistanciaMinistry of Economy and Competitiveness (MINECO) - Government of SpainUnknownMemory Functions | Executive FunctionsSpain
-
Ryerson UniversityCompleted
-
University GhentCompleted
-
University GhentUniversity Hospital, Ghent; Research Foundation FlandersRecruitingMajor Depression in RemissionBelgium
-
VA Office of Research and DevelopmentCompleted
-
University GhentUniversity Hospital, Ghent; Research Foundation FlandersCompletedMajor Depression in RemissionBelgium
-
Mclean HospitalNational Institute of Mental Health (NIMH)TerminatedMental Disorders | Impulsive BehaviorUnited States
-
Ludwig-Maximilians - University of MunichGerman Research Foundation; RWTH Aachen University; University of AmsterdamCompletedMajor Depressive DisorderGermany
-
Van Boven, Robert W., M.D.Massachusetts Institute of Technology; The Geneva FoundationUnknownTraumatic Brain Injury | Post Traumatic Stress DisorderUnited States
-
Chang Gung Memorial HospitalCompletedStroke Patients With Cognitive DeclineTaiwan